PLXP
NASDAQ:PLXP
PLx Pharma Inc.
- Stock
Last Close
0.09
12/04 20:00
Market Cap
2.53M
Beta: 3.92
Volume Today
50.38M
Avg: 4.86M
PE Ratio
−0.13
PFCF: −0.06
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 123.19K - | 123.19K 0% | 71.69K - | 1.30M 1,714.33% | |||||
average payables | 354.11K - | 680.63K 92.21% | 790.99K 16.21% | 895.74K 13.24% | 5.73M 539.83% | ||||
average receivables | 9.69K - | 18.81K 94.07% | 18.46K 1.86% | 9.34K 49.39% | 317K 3,293.46% | ||||
book value per share | 26.44 - | 26.12 1.21% | 11.55 55.78% | 0.66 94.31% | 0.74 12.22% | 0.18 76.14% | 1.08 511.21% | 2.19 103.09% | |
capex per share | -0.08 - | -0.07 2.07% | -0.03 63.84% | -0.01 61.27% | |||||
capex to depreciation | -3.26 - | -1.53 53.13% | -0.25 83.93% | ||||||
capex to operating cash flow | 0.04 - | 0.07 70.65% | 0.02 72.30% | 0.01 56.37% | |||||
capex to revenue | -0.69 - | -0.87 25.95% | -0.43 50.84% | -3.35 684.08% | |||||
cash per share | 27.56 - | 27.32 0.86% | 12.87 52.89% | 3.48 72.99% | 1.63 53.06% | 1.57 3.76% | 2.31 47.15% | 2.93 26.98% | |
days of inventory on hand | 186.72 - | ||||||||
days payables outstanding | 805.20 - | ||||||||
days sales outstanding | 9.09 - | 8.84 2.74% | 12.06 36.46% | 28.19 - | |||||
debt to assets | 0.05 - | 0.05 6.99% | 0.12 150.48% | 0.84 576.56% | 0.65 22.67% | 0.92 40.89% | 0.61 33.64% | 0.33 46.37% | |
debt to equity | 0.05 - | 0.05 7.35% | 0.14 171.82% | 5.25 3,603.04% | 1.85 64.69% | 10.79 482.06% | 1.55 85.67% | 0.48 68.76% | |
dividend yield | |||||||||
earnings yield | -0.15 - | -0.18 16.75% | -1.29 624.62% | -0.32 75.35% | 0.07 121.17% | -0.67 1,096.66% | -0.30 54.72% | -0.27 10.29% | |
enterprise value | 62.34M - | 100.41M 61.08% | 1.69M 98.32% | 30.97M 1,735.04% | 6.30M 79.65% | 29.24M 364.05% | 31.80M 8.75% | 120.05M 277.51% | |
enterprise value over ebitda | -4.59 - | -5.36 16.72% | -0.08 98.52% | -2.05 2,490.75% | 2.81 236.98% | -2.12 175.45% | -2.36 11.48% | -3.41 44.18% | |
ev to operating cash flow | -5.53 - | -6.88 24.48% | -0.11 98.43% | -2.33 2,048.99% | -0.66 71.50% | -2.31 248.22% | -2.60 12.43% | -3.74 43.91% | |
ev to sales | 39.78 - | 8.37 78.96% | 51.71 518.04% | 1.05K 1,920.75% | 14.63 98.60% | ||||
free cash flow per share | -11.49 - | -12.38 7.70% | -12.03 2.82% | -1.97 83.60% | -1.16 41.04% | -1.45 24.44% | -1.27 12.17% | -1.36 6.87% | |
free cash flow yield | -0.13 - | -0.14 9.48% | -0.94 580.23% | -0.29 69.58% | -0.76 165.87% | -0.33 56.43% | -0.23 30.47% | -0.17 26.35% | |
graham net net | 26.27 - | 25.96 1.19% | 11.23 56.73% | 0.04 99.61% | 0.27 501.75% | -0.33 223.19% | 0.65 299.95% | 1.95 198.12% | |
graham number | 90.74 - | 96.66 6.52% | 65.40 32.34% | 5.69 91.30% | 1.31 77.04% | 3.40 160.60% | 6.36 86.98% | 10.34 62.59% | |
income quality | 0.83 - | 0.78 6.23% | 0.73 6.13% | 0.87 18.63% | -10.60 1,322.07% | 0.62 105.83% | 0.80 30.37% | 0.70 13.49% | |
intangibles to total assets | 0 - | 0 | 0 | 0.07 Infinity% | 0.11 56.88% | 0.11 0.62% | 0.08 30.48% | 0.03 65.27% | |
interest coverage | -13.60 - | -9.57 29.68% | -14.27 49.20% | -43.71 206.19% | -7.65 82.51% | ||||
interest debt per share | 1.15 - | 0.95 17.34% | 0.59 38.01% | 0.10 83.82% | 0.23 135.59% | ||||
inventory turnover | 1.95 - | ||||||||
invested capital | 1.50 - | 1.12 25.81% | 2.73 144.42% | 0.06 97.82% | |||||
market cap | 89.38M - | 105.65M 18.20% | 16.59M 84.30% | 48.43M 192.03% | 13.36M 72.41% | 38.96M 191.60% | 53.63M 37.63% | 189.44M 253.26% | |
net current asset value | 25.90M - | 30.75M 18.73% | 14.91M 51.51% | 1.46M 90.22% | 2.92M 100.40% | -2.65M 190.71% | 6.82M 357.44% | 48.51M 611.15% | |
net debt to ebitda | 1.99 - | 0.28 85.97% | 0.70 150.16% | 1.16 65.49% | -3.15 372.19% | 0.70 122.39% | 1.62 130.17% | 1.97 21.42% | |
net income per share | -13.84 - | -15.90 14.86% | -16.45 3.52% | -2.19 86.72% | 0.10 104.70% | -2.92 2,946.67% | -1.67 42.80% | -2.18 30.17% | |
operating cash flow per share | -11.49 - | -12.38 7.70% | -12.03 2.82% | -1.90 84.24% | -1.09 42.61% | -1.42 30.53% | -1.26 11.23% | -1.36 7.76% | |
payables turnover | 0.45 - | ||||||||
receivables turnover | 40.17 - | 41.30 2.82% | 30.27 26.72% | 12.95 - | |||||
research and ddevelopement to revenue | 5.34 - | 5.21 2.45% | 8.38 60.97% | 142.59 1,600.62% | 0.51 99.64% | ||||
return on tangible assets | -0.50 - | -0.58 15.87% | -1.25 115.71% | -0.57 54.08% | 0.05 109.58% | -1.58 2,986.10% | -0.66 58.27% | -0.69 4.34% | |
revenue per share | 0.11 - | 0.09 22.25% | 0.06 26.46% | 0.00 95.06% | 0.35 10,979.92% | ||||
roe | -0.52 - | -0.61 16.27% | -1.42 134.08% | -3.32 133.40% | 0.14 104.18% | -16.60 12,032.29% | -1.55 90.64% | -1.00 35.90% | |
roic | 0.51 - | -0.86 269.24% | 1.31 253.64% | 0.72 44.95% | 1.02 40.75% | 1.73 69.97% | 0.75 56.63% | 0.63 16.65% | |
sales general and administrative to revenue | 13.07 - | 10.35 20.83% | 17.73 71.39% | 300.71 1,595.88% | |||||
shareholders equity per share | 26.44 - | 26.12 1.21% | 11.55 55.78% | 0.66 94.31% | 0.74 12.22% | 0.18 76.14% | 1.08 511.21% | 2.19 103.09% | |
stock based compensation to revenue | 2.09 - | 1.12 46.44% | 1.55 38.63% | 42.34 2,633.59% | 0.35 99.17% | ||||
tangible asset value | 25.95M - | 30.80M 18.70% | 14.97M 51.40% | 2.56M 82.93% | 4.38M 71.53% | -491.40K 111.21% | 8.39M 1,807.76% | 49.62M 491.26% | |
tangible book value per share | 26.44 - | 26.12 1.21% | 11.55 55.78% | 0.36 96.85% | 0.50 37.89% | -0.06 110.98% | 0.86 1,667.35% | 2.10 142.88% | |
working capital | 25.90M - | 30.75M 18.73% | 14.91M 51.51% | 23.87M 60.10% | 10.13M 57.56% | 8.19M 19.17% | 19.44M 137.41% | 61.60M 216.81% |
All numbers in USD (except ratios and percentages)